Top

Published in:

01-08-2013 | Original Article

Financial distress in cancer patients

Authors: Jonas A. de Souza, Yu-Ning Wong

Published in: Journal of Medicine and the Person | Issue 2/2013

Abstract

Novel diagnostic and therapeutic options offer hope to cancer patients with both localized and advanced disease. However, many of these treatments are often costly and even well-insured patients can face high out-of-pocket costs. Families may also be at risk of financial distress due to lost wages and other treatment-related expenses. Research is needed to measure and characterize financial distress in cancer patients and understand how it affects their quality of life. In addition, health care providers need to be trained to counsel patients and their families so they can make patient-centered treatment decisions that reflect their preferences and values.

(2012) Medicare: High-Expenditure Part B Drugs. http://www.gao.gov/assets/650/649459.pdf. Accessed 4 Aug 2013

Schrag D (2004) The price tag on progress—chemotherapy for colorectal cancer. N Engl J Med 351(4):317–319PubMedCrossRef

Wong YN, Meropol NJ, Speier W, Sargent D, Goldberg RM, Beck JR (2009) Cost implications of new treatments for advanced colorectal cancer. Cancer 115(10):2081–2091PubMedCrossRef

Experts in chronic myeloid leukemia (2013) Price of drugs for chronic myeloid leukemia (CML), reflection of the unsustainable cancer drug prices: perspective of CML Experts. Blood 121(22):4439–4442

Prawitz AD, Garman ET, Sorhaindo B, O’Neill B, Kim J, Drentea P (2006) InCharge Financial Distress/Financial Well-Being Scale: development, administration, and score interpretation. Financ Couns Plan 17(1):34–50

Walson C, Fitzsimmons V (1993) Financial manager’s perception of rural household Economie Well-Being: development and testing of a composite measure. J Fam Econ Issue 14(3):193–214CrossRef

Rettig K, Leichtentritt R, Danes S (1999) The effects of resources, decision making, and decision implementing on perceived family well-being in adjusting to an economic stressor. J Fam Econ Issue 20(1):5–34CrossRef

Joo S, Garman ET (1998) The relationship between personal financial wellness and employee productivity: a conceptual model. Pers Financ Work Prod 2(2):162–171

Kim J (1999) Financial satisfaction, personal financework conflict, and work outcomes: pay satisfaction, organizational commitment, and productivity. Paper presented at Association for financial counseling and planning education 1999

10.

Joo S, Grable J (2004) An exploratory framework of the determinants of financial satisfaction. J Fam Econ Issue 25(1):25–50CrossRef

11.

Danes S, Rettig K (1993) The role of perception in the intention to change the family financial situation. J Fam Econ Issue 14(4):365–389CrossRef

12.

Aldana SG (1998) Validity and reliability of a financial strain survey. J Financ Counsel Plan 9(2):11–19

13.

Bailey WC, Woodiel DK, Turner MJ, Young J (1998) The relationship of financial stress to overall stress and satisfaction. Pers Financ Work Prod 2(2):198–207

14.

Freeman C, Carlson J, Sperry L (1993) Adlerian marital therapy strategies with middle income couples facing financial stress. Am J Fam Ther 21(4):324–332CrossRef

15.

Kim J, Garman ET, Sorhaindo B (2003) Relationships among credit counseling clients’ financial well-being, financial behaviors, financial stressor events, and health. J Assoc Financ Counsel Plan Educ 14(2):75–87

16.

Drentea P (2000) Age, debt and anxiety. J Health Soc Behav 41(4):437–450PubMedCrossRef

17.

Mills RJ, Grasmick HG, Morgan CS, Wenk D (1992) The effects of gender, family satisfaction, and economic strain on psychological well-being. Fam Relat 41(4):440–445CrossRef

18.

Voydanoff P (1990) Economic distress and family relations: a review of the eighties. J Marriage Fam 52(4):1099–1115CrossRef

19.

Voydanoff P (1984) Economic distress and families: policy issues. J Fam Issues 5(2):273–288CrossRef

20.

Bernard DM, Banthin JS, Encinosa WE (2006) Health care expenditure burdens among adults with diabetes in 2001. Med Care 44(3):210–215. doi:10.1097/01.mlr.0000199729.25503.60 PubMedCrossRef

21.

Selden TM, Banthin JS (2003) Health care expenditure burdens among elderly adults: 1987 and 1996. Med Care 41:III-13–III-23

22.

Banthin JS, Bernard DM (2006) Changes in financial burdens for health care. JAMA 296(22):2712–2719PubMedCrossRef

23.

Banthin JS, Cunningham P, Bernard DM (2008) Financial burden of health care, 2001–2004. Health Aff 27(1):188–195CrossRef

24.

Bernard DSM, Farr SL, Fang Z (2011) National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol 29(20):2821–2826PubMedCrossRef

25.

Goldman DP, Joyce GF, Zheng Y (2007) Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA 298(1):61–69PubMedCrossRef

26.

Newhouse JP, Manning WG, Morris CN et al (1981) Some interim results from a controlled trial of cost sharing in health insurance. N Engl J Med 305(25):1501–1507PubMedCrossRef

27.

Newhouse JP (2004) Consumer-directed health plans and the rand health insurance experiment. Health Aff 23(6):107–113CrossRef

28.

Goldman DP, Joyce GF, Escarce JJ et al (2004) Pharmacy benefits and the use of drugs by the chronically ill. JAMA 291(19):2344–2350PubMedCrossRef

29.

Hsu J, Price M, Huang J et al (2006) Unintended consequences of caps on medicare drug benefits. N Engl J Med 354(22):2349–2359PubMedCrossRef

30.

Trivedi AN, Rakowski W, Ayanian JZ (2008) Effect of cost sharing on screening mammography in medicare health plans. N Engl J Med 358(4):375–383PubMedCrossRef

31.

Neugut AI, Subar M, Wilde ET et al (2011) Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol 29(18):2534–2542PubMedCrossRef

32.

Streeter SB, Schwartzberg L, Husain N, Johnsrud M (2011) Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions. Am J Manag Care 17(Suppl 5 Developing):SP38–SP44

33.

Wong YN, Hamilton O, Egleston B, Salador K, Murphy C, Meropol NJ (2010) Understanding how out-of-pocket expenses, treatment value, and patient characteristics influence treatment choices. Oncologist 15(6):566–576PubMedCrossRef

34.

Zafar SY, Peppercorn JM, Schrag D et al (2013) The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist 18(4):381–390PubMedCrossRef

35.

Himmelstein DU, Thorne D, Warren E, Woolhandler S (2009) Medical Bankruptcy in the United States, 2007: results of a National Study. Am J Med 122(8):741–746PubMedCrossRef

36.

Ramsey S, Blough D, Kirchhoff A et al (2013) Washington state cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood) 32(6):1143–1152CrossRef

37.

Hagerty RG, Butow PN, Ellis PM et al (2005) Communicating with realism and hope: incurable cancer patients’ views on the disclosure of prognosis. J Clin Oncol 23(6):1278–1288PubMedCrossRef

38.

Mileshkin L, Schofield PE, Jefford M et al (2009) To tell or not to tell: the community wants to know about expensive anticancer drugs as a potential treatment option. J Clin Oncol 27(34):5830–5837PubMedCrossRef

39.

Bullock AJ, Hofstatter EW, Yushak ML, Buss MK (2012) Understanding patients’ attitudes toward communication about the cost of cancer care. J Oncol Pract 8(4):e50–e58PubMedCrossRef

40.

Sommers R, Goold SD, McGlynn EA, Pearson SD, Danis M (2013) Focus groups highlight that many patients object to clinicians’ focusing on costs. Health Aff 32(2):338–346CrossRef

41.

Schnipper LE (2009) ASCO task force on the cost of cancer care. J Oncol Pract 5(5):218–219PubMedCrossRef

42.

Lipscomb J, Gotay CC, Snyder CF (2007) Patient-reported outcomes in cancer: a review of recent research and policy initiatives. CA Cancer J Clin 57(5):278–300PubMedCrossRef

43.

Hlubocky FJ, Cella D, Sher TG, Ratain MJ, Daugherty C (2012) Financial burdens (FB), quality of life, and psychological distress among advanced cancer patients (ACP) in phase I trials and their spousal caregivers (SC). ASCO Meet Abstr 30(15_suppl):6117

44.

Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376PubMedCrossRef

45.

Weeks JC, Cook EF, O’Day SJ et al (1998) Relationship between cancer patients’ predictions of prognosis and their treatment preferences. JAMA 279(21):1709–1714PubMedCrossRef

46.

Hofstatter EW (2010) Understanding patient perspectives on communication about the cost of cancer care: a review of the literature. J Oncol Pract 6(4):188–192PubMedCrossRef

47.

Schrag D, Hanger M (2007) Medical oncologists’ views on communicating with patients about chemotherapy costs: a pilot survey. J Clin Oncol 25(2):233–237PubMedCrossRef

Title: Financial distress in cancer patients
Authors: Jonas A. de Souza
Yu-Ning Wong
Publication date: 01-08-2013
Publisher: Springer Milan
Published in: Journal of Medicine and the Person / Issue 2/2013
Print ISSN: 2035-9411
Electronic ISSN: 2036-3877
DOI: https://doi.org/10.1007/s12682-013-0152-3

At a glance: The STEP trials

Springer Medicine

Financial distress in cancer patients

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2013

Critical reflections on value in medicine

The eradication of Guinea Worm Disease: a possible global public health achievement

More on value(s)

Clinical pathways leading healthcare reform: transformational strategies for oncology and beyond

Usefulness of subacute care for older patients discharged from acute care hospitals: a prospective observational study in Crema

Spirituality as an essential element of person-centered compassionate care: a pilot training program for clinicians